Intana Bioscience
Pre-clinicalMeasuring binding interaction in physiological environments (lysates, serum, vitreous fluid) is feasible with fluorescent cross-correlation spectroscopy-FCCS. Intana offers assay development & screening services based on FCCS
Founded
2015
Focus
Drug DeliverySmall Molecules
About
Measuring binding interaction in physiological environments (lysates, serum, vitreous fluid) is feasible with fluorescent cross-correlation spectroscopy-FCCS. Intana offers assay development & screening services based on FCCS
Funding History
2Total raised: $8.3M
Series A$6.5MBoehringer Ingelheim Venture FundSep 15, 2022
Seed$1.8MHigh-Tech GründerfondsMar 15, 2020
Company Info
TypePrivate
Founded2015
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile